These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 12798954

  • 1. Multiple cellular electrophysiological effects of azimilide in canine cardiac preparations.
    Takács J, Iost N, Lengyel C, Virág L, Nesic M, Varró A, Papp JG.
    Eur J Pharmacol; 2003 Jun 06; 470(3):163-70. PubMed ID: 12798954
    [Abstract] [Full Text] [Related]

  • 2. Azimilide (NE-10064) can prolong or shorten the action potential duration in canine ventricular myocytes: dependence on blockade of K, Ca, and Na channels.
    Yao JA, Tseng GN.
    J Cardiovasc Electrophysiol; 1997 Feb 06; 8(2):184-98. PubMed ID: 9048249
    [Abstract] [Full Text] [Related]

  • 3. Azimilide causes reverse rate-dependent block while reducing both components of delayed-rectifier current in canine ventricular myocytes.
    Gintant GA.
    J Cardiovasc Pharmacol; 1998 Jun 06; 31(6):945-53. PubMed ID: 9641481
    [Abstract] [Full Text] [Related]

  • 4. Combined potassium and calcium channel antagonistic activities as a basis for neutral frequency dependent increase in action potential duration: comparison between BRL-32872 and azimilide.
    Bril A, Forest MC, Cheval B, Faivre JF.
    Cardiovasc Res; 1998 Jan 06; 37(1):130-40. PubMed ID: 9539867
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the rate-dependent properties of the class III antiarrhythmic agents azimilide (NE-10064) and E-4031: considerations on the mechanism of reverse rate-dependent action potential prolongation.
    Groh WJ, Gibson KJ, Maylie JG.
    J Cardiovasc Electrophysiol; 1997 May 06; 8(5):529-36. PubMed ID: 9160229
    [Abstract] [Full Text] [Related]

  • 6. Use-dependent effects of the class III antiarrhythmic agent NE-10064 (azimilide) on cardiac repolarization: block of delayed rectifier potassium and L-type calcium currents.
    Fermini B, Jurkiewicz NK, Jow B, Guinosso PJ, Baskin EP, Lynch JJ, Salata JJ.
    J Cardiovasc Pharmacol; 1995 Aug 06; 26(2):259-71. PubMed ID: 7475051
    [Abstract] [Full Text] [Related]

  • 7. Azimilide inhibits multiple cardiac potassium currents in human atrial myocytes.
    Chen F, Esmailian F, Sun W, Wetzel GT, Sarma JS, Singh BN, Klitzner TS.
    J Cardiovasc Pharmacol Ther; 2002 Oct 06; 7(4):255-64. PubMed ID: 12490972
    [Abstract] [Full Text] [Related]

  • 8. Analysis of the electrophysiological effects of ambasilide, a new antiarrhythmic agent, in canine isolated ventricular muscle and purkinje fibers.
    Baláti B, Iost N, Simon J, Varró A, Papp JG.
    Gen Pharmacol; 2000 Feb 06; 34(2):85-93. PubMed ID: 10974415
    [Abstract] [Full Text] [Related]

  • 9. Electrophysiological effects of EGIS-7229, a new antiarrhythmic agent, in isolated mammalian and human cardiac tissues.
    Pankucsi C, Bányász T, Magyar J, Gyönös I, Kovács A, Varró A, Szénási G, Nánási PP.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar 06; 355(3):398-405. PubMed ID: 9089672
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of azimilide on the muscarinic acetylcholine receptor-operated K+ current and experimental atrial fibrillation in guinea-pig hearts.
    Nishida A, Reien Y, Ogura T, Uemura H, Tamagawa M, Yabana H, Nakaya H.
    J Pharmacol Sci; 2007 Nov 06; 105(3):229-39. PubMed ID: 17965539
    [Abstract] [Full Text] [Related]

  • 13. Cellular electrophysiological effect of terikalant in the dog heart.
    Biliczki P, Acsai K, Virág L, Tálosi L, Jost N, Biliczki A, Papp JG, Varró A.
    Eur J Pharmacol; 2005 Mar 14; 510(3):161-6. PubMed ID: 15763239
    [Abstract] [Full Text] [Related]

  • 14. Electrophysiologic characterization of dronedarone in guinea pig ventricular cells.
    Gautier P, Guillemare E, Marion A, Bertrand JP, Tourneur Y, Nisato D.
    J Cardiovasc Pharmacol; 2003 Feb 14; 41(2):191-202. PubMed ID: 12548079
    [Abstract] [Full Text] [Related]

  • 15. Effect of a neuroprotective drug, eliprodil on cardiac repolarisation: importance of the decreased repolarisation reserve in the development of proarrhythmic risk.
    Lengyel C, Dézsi L, Biliczki P, Horváth C, Virág L, Iost N, Németh M, Tálosi L, Papp JG, Varró A.
    Br J Pharmacol; 2004 Sep 14; 143(1):152-8. PubMed ID: 15302678
    [Abstract] [Full Text] [Related]

  • 16. Effects of sildenafil on cardiac repolarization.
    Chiang CE, Luk HN, Wang TM, Ding PY.
    Cardiovasc Res; 2002 Aug 01; 55(2):290-9. PubMed ID: 12123768
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The role of the delayed rectifier component IKs in dog ventricular muscle and Purkinje fibre repolarization.
    Varro A, Baláti B, Iost N, Takács J, Virág L, Lathrop DA, Csaba L, Tálosi L, Papp JG.
    J Physiol; 2000 Feb 15; 523 Pt 1(Pt 1):67-81. PubMed ID: 10675203
    [Abstract] [Full Text] [Related]

  • 19. Multiple cellular electrophysiological effects of a novel antiarrhythmic furoquinoline derivative HA-7 [N-benzyl-7-methoxy-2,3,4,9-tetrahydrofuro[2,3-b]quinoline-3,4-dione] in guinea pig cardiac preparations.
    Chang GJ, Su MJ, Kuo SC, Lin TP, Lee YS.
    J Pharmacol Exp Ther; 2006 Jan 15; 316(1):380-91. PubMed ID: 16174797
    [Abstract] [Full Text] [Related]

  • 20. The effect of isoproterenol on the class III effect of azimilide in humans.
    Dorian P, Dunnmon P, Elstun L, Newman D.
    J Cardiovasc Pharmacol Ther; 2002 Oct 15; 7(4):211-7. PubMed ID: 12490966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.